Vanta Bioscience Chart
Vanta Bioscience Share Key Metrics
Volume
0.00
Market Cap
13.16 CR
LTQ@LTP
0@18.50
ATP
0
Var Margin
100 %
Circuit Range
14.8-22.2
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
750
Summary
Vanta Bioscience Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0.96
Div. Yield
0
Sector P/E
22.22
Sector P/B
2.72
Sec. Div. Yield
1.19
Vanta Bioscience Resistance and Support
Pivot 18.33
Resistance
First Resistance
18.66
Second Resistance
18.83
Third Resistance
19.16
Support
First Support
18.16
Second Support
17.83
Third Support
17.66
Vanta Bioscience Corporate Actions
| Date | Agenda |
|---|---|
| 2025-11-14 | Half Yearly Results |
| 2025-08-01 | Audited Results |
| 2025-07-29 | Audited Results |
| 2025-07-24 | Audited Results |
| 2025-07-19 | Audited Results |
| 2025-05-30 | Audited Results |
Vanta Bioscience News
NABL's recommendation to continue Biological Testing accreditation granted to Vanta Bioscience
Jul 14 2021 09:51:11
About Vanta Bioscience
NSE : 0
BSE : 540729
ISIN : INE695X01011
The Company was originally incorporated as a private limited company under the Companies Act 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies Hyderabad dated April 29 2016 with the name “Vanta Bioscience Private Limited‘. The Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13 2017 and consequently the name of the Company was changed to “Vanta Bioscience Limited” and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies Hyderabad on March 17 2017. The corporate identification number is U74999TG2016PLC109280. The changes to the name of the Company were undertaken upon conversion of the Company from a private limited company to a public limited company. Major Events and Milestones 2016- Incorporation of the Company 2017- The Company concluded the purchase of the preclinical CRO facility at Gummidipundi Chennai from Kemin Industries South Asia Private Limited which was named as Vanta Bioscience (a toxicology division of Kemin Industries South Asia Private Limited) along with leasehold rights in 4.8 acres of land situated at Plot K2B SIPCOT Industrial Estate Gummidipundi Chennai – 601201.
Vanta Bioscience Management
| Name | Position |
|---|---|
| Mr. Dopesh Raja Mulakala | Managing Director |
| Dr. Yogeswara Rao Danda | Ind. Non-Executive Director |
Vanta Bioscience Similar Stocks
South Asian Enterprises Ltd.
34.00
-1.70 (4.76%)
Quasar India Ltd.
0.28
0.00 (0.00%)
Lypsa Gems & Jewellery Ltd.
4.90
0.20 (4.26%)
Reetech International Ltd.
0.00
0.00 (0.00%)
Triveni Enterprises Ltd.
1.12
0.00 (0.00%)
Simplex Mills Company Ltd.
0.00
0.00 (0.00%)
Alchemist Corporation Ltd.
0.00
0.00 (0.00%)
White Organic Agro Ltd.
3.83
0.03 (0.79%)
Olympic Oil Industries Ltd.
31.10
-0.43 (1.36%)
Vanta Bioscience FAQs
